Nano Letters is a monthly peer-reviewed scientific journal published by the American Chemical Society. It was established in January 2001. The two editors-in-chief are A. Paul Alivisatos (University of California, Berkeley) and Charles M. Lieber (Harvard University). The 2010 impact factor for Nano Letters is 12.219, according to the Journal Citation Reports. The focus of the journal is rapid dissemination of selected elements regarding fundamental, original research reports on all topics related to the theory and practice of nanoscience and nanotechnology and their subdisciplines. Physical, chemical, and biological phenomena related to nanoscience and nanotechnology are part of this focus. Furthermore nanoscale materials science is also included, focusing on processes and applications of structures at this size. Subject coverage encompasses the following: Materials that are synthesized and processed by physical, chemical, and biological methods. The classes of these materials are organic, inorganic, and hybrid. Furthermore, these processes are subjects of modeling and simulation. Specifically these process range from synthesis to assembly, along with relevant interactions.

American Chemical Society
United States
Impact factor
12.219 (2010)

Some content from Wikipedia, licensed under CC BY-SA

Biomolecular sliding at the nanoscale

In organisms whose cells have a nucleus, like plants and animals, the basic packaging units of DNA are the so-called nucleosomes. A nucleosome consists of a segment of DNA wound around eight proteins known as histones. Gene ...

Light-induced acceleration of intracellular delivery

Cell membranes are barriers that maintain cellular homeostasis, and the intracellular delivery of biologically functional molecules, including peptides, proteins, and nucleic acids to manipulate cellular functions. Conventional ...

Nanoscopic tool assesses alternative COVID-19 prevention

Researchers at Kanazawa University report in Nano Letters how high-speed atomic force microscopy can be used to assess the effectivity of spike-neutralizing antibodies for preventing COVID-19. The use of such antibodies offers ...

page 1 from 40